Genmab A (GMAB) Operating Income (2023 - 2026)
Genmab A (GMAB) reported Operating Income of $375 million for the quarter ended Jun 30, 2026, up 108.3% from the prior quarter.
Powered by 
Analysis
Genmab A (GMAB) Operating Income (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Genmab A's Operating Income came in at $2.11 billion; for the year ended Dec 31, 2025, it was $1.07 billion, up 9.6% from the prior year.
- Operating Income has a five-year compound annual growth rate of 15.3% (years ended Dec 2020 to Dec 2025).
- By year, Operating Income came in at $972 million in the year ended Dec 31, 2024 (+25.9%), $772 million in the year ended Dec 31, 2023 (-10.8%), $865 million in the year ended Dec 31, 2022 (+153.7%) and $341.02 million in the year ended Dec 31, 2021 (-34.7%).
- Five-year quarterly Operating Income spans a low of $88.93 million in the quarter ended Dec 31, 2021 and a high of $1.01 billion in the quarter ended Sep 30, 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.08 Bn | 1,101.67 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 616.40 Bn | 534.93 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 501.19 Bn | 474.31 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 367.18 Bn | 321.56 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 297.99 Bn | 261.98 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 261.67 Bn | 235.36 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 235.57 Bn | 190.97 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 190.62 Bn | 164.82 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 169.63 Bn | 116.28 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Genmab A | 2.55 Bn | -2.82 Bn | 1.07 Bn | 375.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 375.00 Mn |
| Mar 31, 2026 | 180.00 Mn |
| Sep 30, 2025 | 459.00 Mn |
| Jun 30, 2025 | 360.00 Mn |
| Mar 31, 2025 | 188.00 Mn |
| Sep 30, 2024 | 310.00 Mn |
| Jun 30, 2024 | 236.00 Mn |
| Mar 31, 2024 | 116.00 Mn |
| Dec 31, 2023 | -2.80 Bn |
| Sep 30, 2023 | 1.69 Bn |
API Access
Genmab A Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=GMAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "GMAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=GMAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();